SCHEMBL301342

SCHEMBL301342

COc1ccccc1-n1c(=O)[nH]c2c(C(N)=O)nc(NCCO)nc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.65
HPGD P15428 4/20 0.65
ALDH1A1 P00352 4/20 0.62
GLA P06280 2/20 0.62
GAA P10253 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
KMT2A Q03164 3/20 0.50
HDAC3 O15379 3/20 0.49
HDAC4 P56524 3/20 0.49
HDAC1 Q13547 3/20 0.49
HDAC7 Q8WUI4 3/20 0.49
HDAC2 Q92769 3/20 0.49
HDAC10 Q969S8 3/20 0.49
HDAC11 Q96DB2 3/20 0.49
HDAC8 Q9BY41 3/20 0.49
HDAC6 Q9UBN7 3/20 0.49
HDAC9 Q9UKV0 3/20 0.49
HDAC5 Q9UQL6 3/20 0.49
HSD17B10 Q99714 3/20 0.49
USP2 O75604 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1750011 0.93 KDM4E (0.60) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300939 0.84 KDM4E (0.62) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL4048756 0.83 KDM4E (0.49) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300971 0.83 KDM4E (0.62) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL27775389 0.82 CSNK2A1 (0.62) KDM4EHPGDALDH1A1GAAKMT2A
SCHEMBL28299693 0.82 KDM4E (0.46) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL301233 0.82 KDM4E (0.61) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300897 0.82 KDM4E (0.57) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300898 0.82 KDM4E (0.57) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL301231 0.82 KDM4E (0.57) KDM4EHPGDALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-B1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARM LLC (US) 2012-03-14 EP claimed
CN-107976546-B Inhibition of phosphorylation of TOR kinase inhibitory Activity markers PRAS40, GSK 3-beta, or P70S6K1 西格诺药品有限公司 2020-10-27 CN disclosed
CN-110721186-A Treatment of prostate cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-24 CN disclosed
CN-107157990-B Treatment of cancer with TOR kinase inhibitors 西格诺药品有限公司 2020-01-07 CN disclosed
CN-109846884-A With TOR kinase inhibitor for treating cancer 西格诺药品有限公司 2019-06-07 CN disclosed
CN-104271138-A Treatment of cancer with tor kinase inhibitors SIGNAL PHARM LLC 2015-01-07 CN disclosed
CN-104271139-A Treatment of cancer with tor kinase inhibitors SIGNAL PHARM LLC 2015-01-07 CN disclosed